Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
01/2007
01/11/2007CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists
01/10/2007EP1740535A1 Thio-substituted methanesulfinyl derivatives
01/10/2007EP1740534A1 Process for purifying mesotrione
01/10/2007EP1740530A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
01/10/2007EP1740524A2 Process for the production of cyclic diketones
01/10/2007EP1740522A2 Bisphenyl compounds useful as vitamin d sb 3 /sb receptor agonists
01/10/2007CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/10/2007CN1294116C Recording material and recording sheet
01/09/2007US7161032 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof
01/09/2007US7161022 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
01/09/2007US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease
01/09/2007US7160955 Polymers with oxygen stability, heat resistance, radiation resistance and ozone resistance for polymers such as polybutadiene modified with sulfur or sulfoxide groups
01/09/2007US7160907 Pleuromutilin derivatives
01/09/2007US7160905 Hydroxyethylene compounds with Asp2 inhibitory activity
01/09/2007US7160903 Sulfonylaminocarboxylic acids
01/09/2007US7160874 Phenylalanine derivatives
01/04/2007WO2007001245A2 Process for improving the lubricating properties of base oils using isomerized petroleum product
01/04/2007US20070004799 Novel compounds for the treatment of obesity
01/04/2007US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents
01/04/2007US20070004643 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma
01/03/2007EP1739143A1 Surface treating agent, fluorine-containing monomer and fluorine-containing polymer
01/03/2007EP1737815A1 Thio-substituted biaryl-methanesulfinyl derivatives
01/03/2007EP1737811A1 Cetp inhibitors
01/03/2007EP1334661B1 Ectoparasitic insect pest controllers for animals and their usage
01/03/2007EP1277726B1 Process for the preparation of 2-halobenzoic acids
01/03/2007EP1265850B1 Insecticidal anthranilamides
01/03/2007CN1890210A Alpha-ketoamide derivative, and production method and use thereof
01/03/2007CN1887864A Method of purifying and detecting metal ion in dimethyl sulfoxide
01/03/2007CN1887422A Application of N2O4 as catalyst in dimethyl sulfoxide production
01/02/2007US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders
12/2006
12/28/2006WO2006138660A2 Sphingosine kinase inhibitors
12/28/2006WO2006137395A1 Amide derivative, pesticide containing such compound and use thereof
12/28/2006WO2006137376A1 Amide derivative and pesticide containing such compound
12/28/2006WO2006112742A3 PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES
12/28/2006US20060293385 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid
12/28/2006US20060293352 Phenoxiacetic acid derivatives
12/28/2006US20060292452 Electrolyte solution for secondary battery and secondary battery using same
12/28/2006CA2612507A1 Amide derivative, insecticide containing the same and method for application thereof as insecticide
12/28/2006CA2612338A1 Sphingosine kinase inhibitors
12/28/2006CA2611687A1 Benzamide derivatives and uses related thereto
12/27/2006EP1736486A1 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent
12/27/2006EP1736467A1 Novel sulfonamide derivative
12/27/2006EP1736465A1 Aniline derivatives
12/27/2006EP1735300A1 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/27/2006EP1735275A2 Aryl sulfones and uses related thereto
12/27/2006EP1735268A1 Opioid receptor antagonists
12/27/2006EP0888290B1 Azulenyl nitrone spin trapping agents, methods of making and using same
12/27/2006CN1886368A Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell
12/27/2006CN1292009C Organic anti-reflection polymer and its preparing method
12/27/2006CN1291974C Process for preparation of carotenoids
12/26/2006US7153993 Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid
12/26/2006US7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
12/26/2006US7153813 Substituted aryl ketones
12/21/2006WO2006134341A1 Therapeutic agents
12/21/2006WO2006134040A1 Anthranilic acid derivatives
12/21/2006WO2006133823A1 Benzanilides with insecticidal activity
12/21/2006US20060287539 Chemical intermediates for production of sibutramine
12/21/2006US20060287373 Cathepsin cysteine protease inhibitors
12/21/2006US20060286424 Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell
12/21/2006US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
12/21/2006CA2611910A1 Anthranilic acid derivatives
12/21/2006CA2611376A1 Therapeutic agents
12/20/2006EP1732884A1 Sulphonamide derivatives
12/20/2006EP1434762B1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006CN1882533A 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2006CN1290879C Amorphous tetrafluoroetylene-hexafluoropropylene copolymers its preparation method and uses
12/20/2006CN1290827C Catalytic process for preparing perfluoroethanesulfonyl fluoride and/or perfluorodiethylsulfone
12/20/2006CN1290485C Compounds for a controlled release of active molecules
12/14/2006WO2006131713A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006WO2006131711A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006WO2006131465A1 Reversibly thermochromic compositions
12/14/2006WO2005089269A3 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
12/14/2006US20060280746 (1E)-1-{[(3-amino-4-methoxyphenyl)methyl]sulfinyl}-2-(2,4,6-trimethoxyphenyl)ethene; antiproliferative agents; offers protection from the cytotoxic effects of ionizing radiation and of cytotoxic chemotherapeutic agents
12/14/2006CA2609969A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/13/2006EP1730103A1 Formamide derivatives useful as adrenoceptor
12/13/2006EP1483241A4 Cyclic derivatives as modulators of chemokine receptor activity
12/13/2006EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
12/13/2006CN1878466A Biphenyl derivative or salt thereof, pest control agent containing the same as active ingredient
12/13/2006CN1876627A Method for producing phthalocyanine compound and its intermediate and intermediate compound for the same
12/13/2006CN1289478C Process for preparation of allyl sulfone derivatives and intermediates for preparation
12/13/2006CN1289477C N-substituted phenyl carbamate compound with sterilization activity and method for preparing the same
12/13/2006CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006CN1289466C Pharmaceutical compounds
12/13/2006CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/12/2006US7148259 hydroxyamidines; antibiotic resistance
12/12/2006CA2207583C Process for the production of 2-(substituted benzoyl)1,3 cyclohexanediones
12/07/2006WO2006128287A1 Fluoroalkylamine derivatives as cathepsin inhibitors
12/07/2006WO2006097817A9 N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
12/07/2006US20060276655 Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia
12/07/2006US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
12/07/2006CA2610014A1 Fluoroalkylamine derivatives as cathepsin inhibitors
12/06/2006EP1727822A1 Novel compounds for modulating cell proliferation
12/06/2006EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006CN1874993A Modafinil compositionsc
12/05/2006US7145035 Using palladium alkylation catalyst
12/05/2006US7145015 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain that latter as well as their use for the production of pharmaceutical agents
12/05/2006US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006CA2207572C Process for the production of 2-(substituted benzoyl)-1,3 cyclohexanediones
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 159